Paricalcitol regulatory effect on inflammatory, fibrotic and anticalcificating parameters in renal patient. Far beyond mineral bone disease regulation Laura Salanova Villanueva, Yohana Gil Giraldo, Begoña Santos Sánchez-Rey, Abelardo Aguilera Peralta

A lower proportion of circulating active parathyroid hormone in peritoneal dialysis does not allow the pth inter-method adjustment proposed for haemodialysis M. Luisa González-Casaus, Emilio González-Parra, Carmen Sánchez-González, Marta Albalate, Concepción de la Piedra-Gordo, Elvira Fernández, Vicente Torregrosa, Mariano Rodríguez, Víctor Lorenzo

The role of Fibroblast Growth Factor 23 in chronic kidney disease-mineral and bone disorder Hugo Diniz, João M. Frazão